Inventor · disambiguated record
Richard S. Geary
Also filed as: GEARY RICHARD · GEARY RICHARD S
18 granted patents·19 pending applications·304 citations·filing 1989–2025
95Inventor score
Files withIONIS PHARMACEUTICALS INC9ISIS PHARMACEUTICALS INC9BHANOT SANJAY8GEARY RICHARD S3SOUTHWEST RES INST3
Top patents by PatentIndex Score
37 records- 0198US9617540B2Compounds and methods for modulating gene expressionIONIS PHARMACEUTICALS INC·Filed 2015·Granted Apr 11, 2017·26 cites·20 claims
- 0298US9045754B2Short antisense compounds with gapmer configurationBHANOT SANJAY·Filed 2007·Granted Jun 2, 2015·56 cites·44 claims
- 0397US8143230B2Compounds and methods for modulating expression of PCSK9BHANOT SANJAY·Filed 2007·Granted Mar 27, 2012·44 cites·46 claims
- 0495US8188059B2Compounds and methods for modulating expression of GCGRBHANOT SANJAY·Filed 2007·Granted May 29, 2012·22 cites·36 claims
- 0593US8586554B2Compounds and methods for modulating expression of PTP1BBHANOT SANJAY·Filed 2007·Granted Nov 19, 2013·13 cites·45 claims
- 0688US8372967B2Compounds and methods for modulating expression of GCCRISIS PHARMACEUTICALS INC·Filed 2007·Granted Feb 12, 2013·5 cites·75 claims
- 0786US8673871B2Compounds and methods for modulating expression ApoBBHANOT SANJAY·Filed 2007·Granted Mar 18, 2014·4 cites·19 claims
- 0883US8362232B2Compounds and methods for modulating expression of SGLT2ISIS PHARMACEUTICALS INC·Filed 2010·Granted Jan 29, 2013·3 cites·46 claims
- 0981US12410430B2Modulating apolipoprotein (A) expressionIONIS PHARMACEUTICALS INC·Filed 2023·Granted Sep 9, 2025·0 cites·5 claims
- 1081US7576067B2Pulsatile release compositions and methods for enhanced intestinal oligonucleotide drug absorptionISIS PHARMACEUTICALS INC·Filed 2004·Granted Aug 18, 2009·16 cites·25 claims
- 1181US5382435AMicroparticulate pharmaceutical delivery systemSOUTHWEST RES INST·Filed 1993·Granted Jan 17, 1995·55 cites·6 claims
- 1277US8969316B2Compounds and methods for modulating expression of DGAT2ISIS PHARMACEUTICALS INC·Filed 2012·Granted Mar 3, 2015·1 cites·20 claims
- 1376US2024165146A1Conjugated Antisense Compounds for Use in TherapyIONIS PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1470US2025319116A1Conjugated Antisense Compounds for Use in TherapyIONIS PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1569US11319536B2Modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2019·Granted May 3, 2022·0 cites·20 claims
- 1668US2015057329A1Compounds and methods for modulating expression apobISIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1765US2016010086A1Oligomeric compounds and excipientsISIS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 1865US2021169917A1Conjugated Antisense Compounds for Use in TherapyIONIS PHARMACEUTICALS INC·Filed 2020·Application pending·0 cites
- 1964US9347061B2Administering antisense oligonucleotides complementary to human apolipoprotein BGEARY RICHARD S·Filed 2008·Granted May 24, 2016·1 cites·31 claims
- 2063US2012208864A1Compounds and methods for modulating expression of gcgrBHANOT SANJAY·Filed 2012·Application pending·0 cites
- 2161US2011256217A1Pulsatile release compositions and methods for enhanced intestinal drug absorptionISIS PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 2259US5505967AMicroparticulate pharmaceutical delivery systemSOUTHWEST RES INST·Filed 1994·Granted Apr 9, 1996·19 cites·6 claims
- 2359US2019046555A1Conjugated antisense compounds for use in therapyIONIS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2458US5167947AEnhancement of absorption of radioprotective drugsSOUTHWEST RES INST·Filed 1989·Granted Dec 1, 1992·21 cites·10 claims
- 2556US10557137B2Modulating apolipoprotein (a) expressionIONIS PHARMACEUTICALS INC·Filed 2016·Granted Feb 11, 2020·0 cites·10 claims
- 2656US6083923ALiposomal oligonucleotide compositions for modulating RAS gene expressionISIS PHARMACEUTICALS INC·Filed 1997·Granted Jul 4, 2000·18 cites·4 claims
- 2755US2024033280A1Methods for reducing apociii expressionIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2853US2009326040A1Antisense modulation of apolipoprotein b expressionISIS PHARMACEUTICALS INC·Filed 2005·Application pending·0 cites
- 2953US2012264806A1Oligomeric compounds and excipientsBENNETT C FRANK·Filed 2010·Application pending·0 cites
- 3051US2009036355A1Antisense Modulation of PTP1B ExpressionBHANOT SANJAY·Filed 2005·Application pending·0 cites
- 3151US2006089325A1Antisense modulation of PTP1B expressionBHANOT SANJAY·Filed 2005·Application pending·0 cites
- 3248US2007299028A1Backbone modifications to modulate oligonucleotide targeting in vivoSIWKOWSKI ANDREW M·Filed 2007·Application pending·0 cites
- 3347US2006035858A1Methods for modulating lipoprotein and cholesterol levels in humansGEARY RICHARD S·Filed 2005·Application pending·0 cites
- 3445US2012115926A1Antisense modulation of apolipoprotein b expressionGEARY RICHARD S·Filed 2011·Application pending·0 cites
- 3545US2003124196A1Pulsatile release compositions and methods for enhanced intestinal drug absorptionFiled 2001·Application pending·0 cites
- 3640US2017096662A1Administering antisense oligonucleotides complementary to human apolipoprotein bKASTLE THERAPEUTICS LLC·Filed 2016·Application pending·0 cites
- 3738US2003083286A1Bioadhesive compositions and methods for enhanced intestinal drug absorptionFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Richard S. Geary files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →